Ali Mobasheri is currently Senior Research Scientist in the Department of Regenerative Medicine at the State Research Institute Centre for Innovative Medicine in Vilnius, Lithuania. From April 2014 to December 2018 he was Professor of Musculoskeletal Physiology at the University of Surrey in the United Kingdom. Ali was educated at Dulwich College in London. After completing his BSc (2.1 Hons) in Biochemistry from Imperial College London in 1990 Ali took up an Open Fellowship at the University of Toronto in Canada and started a three-year Master’s degree in Physiology and Biochemistry in the School of Graduate Studies. Ali returned to the UK in 1993 to work on his Doctorate in Molecular and Cellular Physiology in the University Laboratory of Physiology (now known as the Department of Physiology, Anatomy and Genetics) at the University of Oxford. His doctoral project was generously sponsored by the Arthritis and Rheumatism Council (later known as Arthritis Research UK and now known as Versus Arthritis). Ali was affiliated with Wolfson College Oxford and received his D.Phil. (Oxon.) from the Faculty of Medicine, Oxford University in 1997. Shortly after completing his D.Phil. he worked in the Department of Physiology (now the Centre for Integrative Physiology) at the University of Edinburgh as a Post-Doctoral Research Fellow before his early academic appointments at the University of Westminster in London and the University of Liverpool as Lecturer (1997-2005) and then as Senior Lecturer (2005-2006) at the University of Liverpool. In 2006 he was promoted to Associate Professor and Reader in Comparative Physiology at the University of Nottingham and served as Postgraduate Sub-Dean for 5 years. In February 2013 he was appointed as a Visiting Adjunct Professor in the Distinguished Scientist / Highly Cited Program of King AbdulAziz University, Kingdom of Saudi Arabia. In April 2014 Ali joined the University of Surrey as a Full Professor and Head of the Department of Veterinary Preclinical Sciences. He was appointed Associate Dean (Research & Enterprise) in August 2015 and held this post until February 2017. Ali’s research focuses on cartilage biology, ion channel physiology and biomarkers of osteoarthritis. He successfully co-ordinated the European Commission (EC) Framework 7 (FP7) funded D-BOARD consortium, which brought together leading European academic institutions and SMEs to focus on the identification, validation and qualification of new biomarkers for degenerative and inflammatory diseases of joints. He is also member of the APPROACH Consortium and has received significant funding from the Innovative Medicines Initiative (IMI), a joint undertaking between the and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Ali is a member of the Board of Directors of the Osteoarthritis Research Society International (OARSI) and chaired the OARSI Strategic Alliance Committee until April 2017, when he was elected President-Elect of OARSI. He will serve on the OARSI Fiscal Committee and the OARSI Program Committee until he begins his presidency in April 2019. Ali has served on the Scientific, Ethics and Advisory Board (SEAB) of the FP7 SYBIL (Systems biology for the functional validation of genetic determinants of skeletal diseases) Consortium. Ali has published 246 peer-reviewed papers since 1997. He has been a Faculty Member in F1000Prime in the Rheumatology & Clinical Immunology, Musculoskeletal Repair & Regeneration section. He has received more than 10 million Euros in grant funding since 2012 and contributed to the successful award of 2.5 million pounds to the Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis and further renewal of this centre in September 2017 with a grant of 2 million pounds. His current h-index on Scopus is 49.


Current Positions:

  1. Professor, Project Leader and Senior Research Scientist, State Research Institute Centre for Innovative Medicine, Santariskiu 5, 08661 Vilnius, Republic of Lithuania
  2. President Elect, Osteoarthritis Research Society International (OARSI) and Member of the OARSI Board of Directors
  3. Work Package 2 Co-Lead, Arthritis Research UK Centre for Sport, Exercise and Osteoarthritis
  4. Work Package 2 Co-lead, European Commission Innovative Medicines Initiative (IMI) Project: APPROACH


Other Significant Roles:

  • Scientific Co-ordinator, European Commission 7th Framework Programme Project: D-BOARD
  • Served on Consensus Evaluation Panels for the European Commission in Horizon 2020 in 2014, 2015, 2016, 2017, and 2018
  • Served on three BBSRC committees – Committee A (pool member), BBSRC iCASE Committee (panel member) and Committee as pool and the BBSRC Portfolio Monitoring Group (panel member) from 2012-2018
  • Currently serves on the Arthritis Research UK (Versus Arthritis) Disease Sub-Committee
  • Will serve on the UKRI Future Leaders Fellowships Panel College from January 2019


Public Research Profiles:


ResearcherID: D-5770-2011

Scopus Author ID: 7003311894

Loop: 14340